Abstract
A quantitative structure-activity relationship (QSAR) study has been carried out on acetylcholinesterase (AChE) inhibitors with comparative field analysis (CoMFA), comparative molecular similarity indices analysis (CoMSIA) and hologram quantitative structure-activity relationship (HQSAR). In order to investigate the effect of alignment on modeling and find out the best alignment strategy, three different alignment rules were applied to generate CoMFA and CoMSIA models. Statistical results of the highly significant models (CoMFA q2 = 0.748, r2 =0.996, predicted r2 =0.789; CoMSIA q2 =0.755, r2 =0.973, predicted r,2 = 0.706; HQSAR q,2 = 0.884, r2 = 0.973, predicted r2 = 0.734) reveal considerable predictive ability. Analysis of the contour maps of CoMFA and CoMSIA models and the atomic contribution maps of HQSAR model may contribute to develop novel and potential AChE inhibitors.
Keywords: AChE inhibitors, atom-fit alignment, CoMFA, CoMSIA, database alignment, HQSAR, multi-fit alignment, QSAR.
Current Computer-Aided Drug Design
Title:CoMFA, CoMSIA and HQSAR Studies of Acetylcholinesterase Inhibitors
Volume: 9 Issue: 3
Author(s): Yu-Ren Jiang, Yan-Yan Yang, Yu-Ling Chen and Zhong-Jie Liang
Affiliation:
Keywords: AChE inhibitors, atom-fit alignment, CoMFA, CoMSIA, database alignment, HQSAR, multi-fit alignment, QSAR.
Abstract: A quantitative structure-activity relationship (QSAR) study has been carried out on acetylcholinesterase (AChE) inhibitors with comparative field analysis (CoMFA), comparative molecular similarity indices analysis (CoMSIA) and hologram quantitative structure-activity relationship (HQSAR). In order to investigate the effect of alignment on modeling and find out the best alignment strategy, three different alignment rules were applied to generate CoMFA and CoMSIA models. Statistical results of the highly significant models (CoMFA q2 = 0.748, r2 =0.996, predicted r2 =0.789; CoMSIA q2 =0.755, r2 =0.973, predicted r,2 = 0.706; HQSAR q,2 = 0.884, r2 = 0.973, predicted r2 = 0.734) reveal considerable predictive ability. Analysis of the contour maps of CoMFA and CoMSIA models and the atomic contribution maps of HQSAR model may contribute to develop novel and potential AChE inhibitors.
Export Options
About this article
Cite this article as:
Jiang Yu-Ren, Yang Yan-Yan, Chen Yu-Ling and Liang Zhong-Jie, CoMFA, CoMSIA and HQSAR Studies of Acetylcholinesterase Inhibitors, Current Computer-Aided Drug Design 2013; 9 (3) . https://dx.doi.org/10.2174/15734099113099990015
DOI https://dx.doi.org/10.2174/15734099113099990015 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)
Current Medicinal Chemistry New Agents and Approaches to Treatment in Niemann-Pick Type C Disease
Current Pharmaceutical Biotechnology Pathophysiology of Blood-Spinal Cord Barrier in Traumatic Injury and Repair
Current Pharmaceutical Design Advances in Studies on Stroke-Induced Secondary Neurodegeneration (SND) and Its Treatment
Current Topics in Medicinal Chemistry New Insight into the Mechanisms of <i>Ginkgo Biloba</i> Extract in Vascular Aging Prevention
Current Vascular Pharmacology High Serum Alkaline Phosphatase Levels in Relation to Multi-Cerebral Microbleeds in Acute Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease
Current Neurovascular Research Pathogenesis of Abeta Oligomers in Synaptic Failure
Current Alzheimer Research Treatment Possibilities for Psychosis in Parkinson's Disease with An Emphasis on the Newly Approved Drug: Pimavanserin
CNS & Neurological Disorders - Drug Targets Delineating Somatostatins Neuronal Actions
Current Drug Targets - CNS & Neurological Disorders Visceral Fat as Target of Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome
Current Pharmaceutical Design Inflammatory Biomarkers, Depressive Symptoms and Falls Among the elderly in Panama
Current Aging Science Non-Demented Individuals with Alzheimer’s Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies
Current Pharmaceutical Design Prayer at Midlife is Associated with Reduced Risk of Cognitive Decline in Arabic Women
Current Alzheimer Research The Differential Diagnostic Value of the Callosal Angle and Evans Index in Mild Cognitive Impairment and Alzheimer's Disease
Current Medical Imaging White Matter Damage Along the Uncinate Fasciculus Contributes to Cognitive Decline in AD and DLB
Current Alzheimer Research Radiopharmaceutical: Revolutionary Agents for Diagnosis
Current Radiopharmaceuticals Minocycline and Cytoprotection: Shedding New Light on a Shadowy Controversy
Current Drug Delivery TNF-α Inhibition as a Treatment Strategy for Neurodegenerative Disorders: New Drug Candidates and Targets
Current Alzheimer Research Biomarkers and Cellular Signal Detection for Alzheimer’s Disease, Stroke, and Immune System Mediated Disorders
Current Neurovascular Research Metal Ions and Metal Complexes in Alzheimer’s Disease
Current Pharmaceutical Design